Rapamycin Nano-Micelle Ophthalmic Solution Reduces Corneal Allograft Rejection by Potentiating Myeloid-Derived Suppressor Cells' Function
2018 · Frontiers in Immunology · 37 citations
https://doi.org/10.3389/fimmu.2018.02283
L
Li Ma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
104
Citations
4
h-index
4
i10-index
Li Ma is an academic researcher from Shandong Eye Hospital. The author has contributed to research in topics: Immune Response and Inflammation & Inflammasome and immune disorders & Corneal Surgery and Treatments. The author has an h-index of 4, co-authored 6 publications.
ORCID: 0009-0008-1363-6469Papers by this author
worksThe NLRP3 inflammasome regulates corneal allograft rejection through enhanced phosphorylation of STAT3
2020 · American Journal of Transplantation · 25 citations
https://doi.org/10.1111/ajt.16071
Enhanced autophagy alleviated corneal allograft rejection via inhibiting NLRP3 inflammasome activity
2022 · American Journal of Transplantation · 18 citations
https://doi.org/10.1111/ajt.16968
Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2)
2025 · Investigative Ophthalmology & Visual Science · 1 citations
https://doi.org/10.1167/iovs.66.2.15
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat